Kary Eldred insider trades

Open-market stock purchases and sales by Kary Eldred, Unknown at Galectin Therapeutics Inc, from SEC Form 4 filings since May 22, 2018.

Track record: 69% of 13 scored buys are up 5% or more since purchase, averaging +43%.

Recent trades

DateStockTradeValue
Feb 6, 2026GALT Galectin Therapeutics IncBought$810
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Dec 23, 2025GALT Galectin Therapeutics IncBought$2.6K
Dec 23, 2025GALT Galectin Therapeutics IncBought$2.6K

Companies traded

  • GALT Galectin Therapeutics Inc: 15 buys, last Feb 6, 2026

Get free alerts when Kary Eldred files a new trade →